Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.46 |
| ▸ | NMT2 | O60551 | 2/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.46 |
| ▸ | NMT1 | P30419 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ABCG2 | Q9UNQ0 | 9/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22102054 | 0.90 | GPR35 (0.57) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL15452216 | 0.87 | GPR35 (0.76) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL24310482 | 0.87 | GPR35 (0.52) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL22102052 | 0.87 | GPR35 (0.54) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL26848550 | 0.86 | GPR35 (0.74) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL24310283 | 0.86 | GPR35 (0.53) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL143979 | 0.85 | GPR35 (0.72) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL19935518 | 0.85 | GPR35 (0.65) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL2719029 | 0.84 | GPR35 (0.79) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL19935582 | 0.84 | GPR35 (0.64) | GPR35LMNATDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023230418-A1 | MUTUAL PRODRUGS OF CROMOGLICIC ACID | SAMDOLITE PHARMACEUTICALS LLC (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20220062222-A1 | CROMOLYN ESTERS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION | 2022-03-03 | — | — | US | disclosed |
| WO-2020123449-A1 | CROMOLYN ESTERS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2020-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220062222-A1 | CROMOLYN ESTERS AND USES THEREOF | PRNP, HTT, PSEN1 | GPR35 966/4885LMNA 131/4885TDP1 1061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.